Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis MéxicoNovartis México
VS
Glenmark PharmaceuticalsGlenmark Pharmaceuticals
Novartis México

Novartis México

Insurgentes Sur 2475, Ciudad de Mexico, 01090 , MX

Last Update: 01/03/2026

View Profile
Between 750 and 799
www.novartis.com/mx-es
759/1000Fair

Novartis Farmacéutica, S.A. de C.V. es individualmente “Responsable” de recabar sus datos personales, con domicilio en Av. Insurgentes Sur 2475, Tizapán San Ángel, Álvaro Obregón, 01090 Ciudad de México. Los datos personales que usted nos proporcione serán utilizados pa...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:607
Subsidiaries:43
12-month incidents
0
Known data breaches
0
Attack type number
0
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 12/09/2026

View Profile
650/1000Weak

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,777
Subsidiaries:0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis México

Novartis México

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis México in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 1.96% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Novartis México (X = Date, Y = Severity)

Novartis México cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis México

Novartis México

Incidents
No explicit notable incidents reported.
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Incidents
🔒 Incident : Ransomware
KOPGLE1777473227

FAQ

Between Novartis México company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?
Between Novartis México company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?
Between Novartis México and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Novartis México and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis México or Glenmark Pharmaceuticals ?
Which company is PCI DSS compliant - Novartis México or Glenmark Pharmaceuticals ?
Between Novartis México and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Novartis México and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-111865
SUMMARY

A security flaw has been discovered in THU-MIG yoloe up to 40cd606cabdbe2b566d6f14a6b162c89206e9a1b. This affects the function eval of the file ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. The manipulation of the argument imgsz/names/kpt_shape results in improper neutralization of directives in dynamically evaluated code. The attack requires a local approach. The exploit has been released to the public and may be used for attacks. This product does not use versioning. This is why information about affected and unaffected releases are unavailable. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 4.3
Complexity: LOW
AV:L/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 1.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
1.8
CVE-2026-111934
SUMMARY

Coder before 2.34.7 contains an IP spoofing vulnerability in the ExtractRealIPAddress middleware that trusts the leftmost, client-supplied X-Forwarded-For value instead of the client IP appended by a reverse proxy. Attackers can send forged X-Forwarded-For values through appending proxies to bypass per-IP rate limits on login, one-time passcode, and password validation endpoints, enabling brute-force attacks, and to falsify IP addresses recorded in audit logs.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N
CVSS4
Base Score: 6.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-111933
SUMMARY

Coder before 2.29.17, 2.30.0 before 2.32.7, 2.33.0 before 2.33.8, and 2.34.0 before 2.34.2 contains a user enumeration vulnerability because userpassword.Compare() substitutes a placeholder hash derived from the string "hunter2" when a stored password hash is empty. Unauthenticated attackers can submit logins with the password "hunter2" and distinguish HTTP 403 from 401 responses to enumerate valid accounts and reveal the authentication provider of SSO-only users.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-111932
SUMMARY

Coder before 2.29.17, 2.30.0 before 2.32.7, 2.33.0 before 2.33.8, and 2.34.0 before 2.34.2 contains a stored HTML injection vulnerability because the ApplicationName and LogoURL appearance settings are rendered into HTML output without sufficient escaping. Attackers with the Owner role can store HTML markup in these settings that renders in the Coder dashboard and in SMTP notification emails sent to other deployment users.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 3.4)
CVSS3
Base Score: 3.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:N/I:L/A:N
CVSS4
Base Score: 4.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:P/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.7
CVE-2026-111931
SUMMARY

Coder from 2.0.0 before 2.34.8 contains an open redirect vulnerability in handleAPIKeySmuggling that allows attackers to redirect users externally via unsanitized r.URL.Path values. Attackers can craft links on trusted workspace app subdomains with paths beginning with double slashes, which become scheme-relative redirects to attacker sites for phishing.

PUBLISHED
Date2026-10-17
UPDATED
Date2026-10-17
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8